login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
RADIOPHARM THERANOSTICS LTD (RADX) Stock News
USA
- NASDAQ:RADX -
ADR
4.86
USD
-0.1 (-2.02%)
Last: 11/11/2025, 12:25:22 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
RADX Latest News, Press Relases and Analysis
All
Press Releases
6 days ago - By: Virtual Investor Conferences
- Mentions:
LSE
-
HCM
VIOT
...
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
11 days ago - By: Virtual Investor Conferences
- Mentions:
HCM
LSE
-
YRD
...
CORRECTION -- International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025
9 months ago - By: Benzinga
- Mentions:
SRDX
MRK
Top 3 Health Care Stocks You'll Regret Missing This Month
12 days ago - By: Virtual Investor Conferences
- Mentions:
HCM
LSE
-
YRD
...
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025
15 days ago - By: Benzinga
- Mentions:
AZTR
SNTI
ADAP
CODX
...
12 Health Care Stocks Moving In Monday's After-Market Session
22 days ago - By: Radiopharm Theranostics
Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan
a month ago - By: Radiopharm Theranostics
Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to Accelerate 177Lu-RAD202 Phase 1 ‘HEAT’ Dose Escalation Clinical Trial
4 months ago - By: Radiopharm Theranostics
Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update
4 months ago - By: Radiopharm Theranostics
Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board
5 months ago - By: Radiopharm Theranostics
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹⁶¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
5 months ago - By: Radiopharm Theranostics
Radiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors
5 months ago - By: Radiopharm Theranostics
Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake
6 months ago - By: Radiopharm Theranostics
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177
6 months ago - By: Radiopharm Theranostics
Radiopharm Theranostics to Participate in the D. Boral Capital Inaugural Global Conference
8 months ago - By: Radiopharm Theranostics
New RAD202 Data Confirms Positive Tumor Uptake and Favorable Biodistribution
9 months ago - By: Radiopharm Theranostics
New Clinical Trial Data Highlights RAD 101 (18F-Pivalate) Successfully Detects Brain Metastases
11 months ago - By: Radiopharm Theranostics
Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia
a year ago - By: Radiopharm Theranostics
RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial
Please enable JavaScript to continue using this application.